Exercise-Induced 2:1 Atrioventricular Block as an Early Manifestation of Cardiac Sarcoidosis in a Middle-Aged Man
Open Access
- 27 October 2026
- journal article
- Published by Elsevier in HeartRhythm Case Reports
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Reversible Chronotropic Incompetence in Early Cardiac Sarcoidosis Assessed by Serial Exercise EchocardiographyJACC: Case Reports, 2026
- Management and outcomes of cardiac sarcoidosis diagnosed after permanent pacemaker implantation for high-grade atrioventricular blockHeart Rhythm, 2025
- Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart AssociationCirculation, 2024
- TNF-alpha inhibition for the treatment of cardiac sarcoidosisSeminars in Arthritis and Rheumatism, 2019
- Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registriesEuropean Heart Journal, 2019
- Premature ventricular contraction–induced polymorphic ventricular tachycardia after leadless pacemaker implantation: A unique adverse effect of leadless pacingHeartRhythm Case Reports, 2018
- HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac SarcoidosisHeart Rhythm, 2014
- Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosisEP Europace, 2012
- Exercise Intolerance and Multiple Conduction Abnormalities as First Manifestation of Cardiac SarcoidosisSouthern Medical Journal, 2008
- Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart FailureCirculation, 2003